Panthera Biopartners
Lucinda Patricia Burdett has had five years of work experience. In 2022, they began working as a PA/Head Office Assistant for Panthera Biopartners. From 2018-2022, they were a Teacher at Lancashire County Council. From 2016-2018, they were a Teacher Assistant at Veritas Education Recruitment. From 2013-2016, they were an Office Administrator at ASPRO Security Services, where they gained knowledge and experience in programming equipment, communicating with people all over the UK, and working as part of a team. From 2010-2013, they worked as a Waitress at Hesketh Arms, Rufford, where they started as a Kitchen Porter and then was promoted to the main restaurant, and later to a Barmaid.
Lucinda Patricia Burdett completed a Bachelor's Degree in Fine/Studio Arts, General from Northumbria University in 2016. Lucinda Patricia then went on to pursue a Postgraduate Degree in Education from University of Cumbria in 2017-2018. Lucinda Patricia is currently enrolled in a Postgraduate Degree in Education from University of Cumbria.
This person is not in any offices
Panthera Biopartners
1 followers
Panthera Biopartners, established in 2019, is a leading UK-based Site Management Organisation (SMO) specialising in patient recruitment and the execution of clinical trials across various therapeutic areas. Founded by Dr Ian Smith, the originator of Synexus, and Professor John Lyon, a former global executive at Covance, Panthera has rapidly expanded its network to include dedicated clinical trial sites in major UK cities such as Glasgow, London, Manchester, Preston, Sheffield and York The organisation's mission is to enhance healthcare accessibility by conducting clinical research that integrates diverse insights and expertise. Panthera is committed to maintaining rigorous ethical standards and contributing to medical advancements that positively impact health and well-being. Panthera's management team comprises experienced professionals with extensive knowledge in conducting clinical trials across multiple therapy areas and countries. Key figures include Dr Ian Smith (Co-Founder, Director, and Chief Medical Officer), Stuart Young (Chief Executive Officer), and Chris Dodd (Chief Commercial Officer). In October 2024, Panthera became the first UK clinical trial site organisation to join Parexel’s Site Alliance Vaccine Network, a global consortium of high-performing clinical trial sites. This collaboration underscores Panthera's exceptional performance in patient recruitment and its strong partnership with Parexel. Panthera's dedication to innovation and excellence was recognised in October 2023 when it was named Pharma Research Centre of the Year at the Pharma Industry Awards UK. The award highlighted Panthera's innovative SMO model, which emphasises rapid start-up times, access to a vast pool of prequalified patients, and the digitisation of patient engagement processes.